Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: Evaluation of the protective role of the metabolic modulator trimetazidine
- 6 February 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 39 (3), 413-419
- https://doi.org/10.1016/s0735-1097(01)01768-5
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Regulation of fatty acid oxidation in the mammalian heart in health and diseaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Effects of glucose and fatty acids on myocardial ischaemia and arrhythmiasThe Lancet, 1994
- The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemiaMolecular and Cellular Biochemistry, 1992
- Paradoxical role of lipid metabolism in heart function and dysfunctionMolecular and Cellular Biochemistry, 1992
- Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragmentClinical Physiology and Functional Imaging, 1990
- Immunoreactive endothelin in human plasma: Marked elevations in patients in cardiogenic shockBiochemical and Biophysical Research Communications, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Alterations of carbohydrate and lipid metabolism in the acutely ischemic heartProgress in Cardiovascular Diseases, 1981
- Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacingThe American Journal of Cardiology, 1977
- Beta adrenergic blockade: Hemodynamics and myocardial energy metabolism in patients with ischemic heart diseaseThe American Journal of Cardiology, 1968